Cerus | CERS - Przychody Ze Sprzedaży





Obroty Zmiana Data
Cerus USD 50.81M 4.79M 2024-12
GRIFOLS EUR 1.98B 110M 2025-12
Haemonetics USD 338.97M 11.97M 2025-12
Neogen USD 224.69M 15.5M 2025-09
OraSure Technologies USD 26.76M 322K 2025-12
Plus Therapeutics USD 1.31M 73K 2023-12
Quidel USD 724M 24M 2025-12
Rockwell Medical USD 25.83M 3.15M 2024-06
STAAR Surgical USD 239.4M 144.7M 2025-12
Terumo JPY 296.63B 21.66B 2025-12
Utah Medical Products USD 10M 400K 2024-09